Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Progressive dysexecutive syndrome due to Alzheimer’s disease: a description of 55 cases and comparison to other phenotypes
Ryan Townley, Jonathan Graff‐Radford, William G. Mantyh, et al.
Brain Communications (2020) Vol. 2, Iss. 1
Open Access | Times Cited: 110

Showing 1-25 of 110 citing articles:

Alzheimer disease
David S. Knopman, Hélène Amieva, Ronald C. Petersen, et al.
Nature Reviews Disease Primers (2021) Vol. 7, Iss. 1
Open Access | Times Cited: 1528
Cognitive and behavioural flexibility: neural mechanisms and clinical considerations
Lucina Q. Uddin
Nature reviews. Neuroscience (2021) Vol. 22, Iss. 3, pp. 167-179
Open Access | Times Cited: 455
New insights into atypical Alzheimer's disease in the era of biomarkers
Jonathan Graff‐Radford, Keir Yong, Liana G. Apostolova, et al.
The Lancet Neurology (2021) Vol. 20, Iss. 3, pp. 222-234
Open Access | Times Cited: 427
Advances and controversies in frontotemporal dementia: diagnosis, biomarkers, and therapeutic considerations
Bradley F. Boeve, Adam L. Boxer, Fiona Kumfor, et al.
The Lancet Neurology (2022) Vol. 21, Iss. 3, pp. 258-272
Open Access | Times Cited: 138
Dissecting the clinical heterogeneity of early-onset Alzheimer’s disease
Daniel W. Sirkis, Luke W. Bonham, Taylor P. Johnson, et al.
Molecular Psychiatry (2022) Vol. 27, Iss. 6, pp. 2674-2688
Open Access | Times Cited: 92
Frontotemporal lobar degeneration
Murray Grossman, William W. Seeley, Adam L. Boxer, et al.
Nature Reviews Disease Primers (2023) Vol. 9, Iss. 1
Closed Access | Times Cited: 69
Biomarker-based staging of Alzheimer disease: rationale and clinical applications
Joseph Therriault, Suzanne E. Schindler, Gemma Salvadó, et al.
Nature Reviews Neurology (2024) Vol. 20, Iss. 4, pp. 232-244
Closed Access | Times Cited: 58
Demographic, clinical, biomarker, and neuropathological correlates of posterior cortical atrophy: an international cohort study and individual participant data meta-analysis
Marianne Chapleau, Renaud La Joie, Keir Yong, et al.
The Lancet Neurology (2024) Vol. 23, Iss. 2, pp. 168-177
Open Access | Times Cited: 29
Updated appropriate use criteria for amyloid and tau PET: A report from the Alzheimer's Association and Society for Nuclear Medicine and Molecular Imaging Workgroup
Gil D. Rabinovici, D. S. Knopman, Javier Arbizu, et al.
Alzheimer s & Dementia (2025)
Open Access | Times Cited: 12
Updated Appropriate Use Criteria for Amyloid and Tau PET: A Report from the Alzheimer’s Association and Society for Nuclear Medicine and Molecular Imaging Workgroup
Gil D. Rabinovici, D. S. Knopman, Javier Arbizu, et al.
Journal of Nuclear Medicine (2025), pp. jnumed.124.268756-jnumed.124.268756
Closed Access | Times Cited: 2
Impact of the polygenic risk scores for attention‐deficit/hyperactivity disorder in Alzheimer's disease
Douglas Teixeira Leffa, Guilherme Povala, Bruna Bellaver, et al.
Alzheimer s & Dementia (2025) Vol. 21, Iss. 2
Open Access | Times Cited: 2
Donanemab: Appropriate use recommendations
G D Rabinovici, D. J. Selkoe, Suzanne E. Schindler, et al.
The Journal of Prevention of Alzheimer s Disease (2025), pp. 100150-100150
Open Access | Times Cited: 2
Association of APOE4 and Clinical Variability in Alzheimer Disease With the Pattern of Tau- and Amyloid-PET
Renaud La Joie, Adrienne Visani, Orit H. Lesman‐Segev, et al.
Neurology (2020) Vol. 96, Iss. 5
Open Access | Times Cited: 96
Research Criteria for the Behavioral Variant of Alzheimer Disease
Rik Ossenkoppele, Ellen H. Singleton, Colin Groot, et al.
JAMA Neurology (2021) Vol. 79, Iss. 1, pp. 48-48
Open Access | Times Cited: 89
Predicting future rates of tau accumulation on PET
Clifford R. Jack, Heather J. Wiste, Stephen D. Weigand, et al.
Brain (2020) Vol. 143, Iss. 10, pp. 3136-3150
Open Access | Times Cited: 88
Recent update on the heterogeneity of the Alzheimer’s disease spectrum
K. A. Jellinger
Journal of Neural Transmission (2021) Vol. 129, Iss. 1, pp. 1-24
Closed Access | Times Cited: 87
A computational model of neurodegeneration in Alzheimer’s disease
David T. Jones, Val J. Lowe, Jonathan Graff‐Radford, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 59
Amyloid and tau‐PET in early‐onset AD: Baseline data from the Longitudinal Early‐onset Alzheimer's Disease Study (LEADS)
Hanna Cho, Nidhi S. Mundada, Liana G. Apostolova, et al.
Alzheimer s & Dementia (2023) Vol. 19, Iss. S9
Open Access | Times Cited: 32
Monoclonal antibodies and aptamers: The future therapeutics for Alzheimer's disease
Álvaro Barrera-Ocampo
Acta Pharmaceutica Sinica B (2024) Vol. 14, Iss. 7, pp. 2795-2814
Open Access | Times Cited: 9
Lecanemab for early Alzheimer's disease: Appropriate use recommendations from the French federation of memory clinics
Nicolas Villain, Vincent Planche, Matthieu Lilamand, et al.
The Journal of Prevention of Alzheimer s Disease (2025), pp. 100094-100094
Open Access | Times Cited: 1
New developments of biofluid‐based biomarkers for routine diagnosis and disease trajectories in frontotemporal dementia
Marta del Campo, Henrik Zetterberg, Sam Gandy, et al.
Alzheimer s & Dementia (2022) Vol. 18, Iss. 11, pp. 2292-2307
Open Access | Times Cited: 29
The Sporadic Early‐onset Alzheimer's Disease Signature Of Atrophy: Preliminary Findings From The Longitudinal Early‐onset Alzheimer's Disease Study (LEADS) Cohort
Alexandra Touroutoglou, Yuta Katsumi, Michael Brickhouse, et al.
Alzheimer s & Dementia (2023) Vol. 19, Iss. S9
Open Access | Times Cited: 18
Deciphering the clinico-radiological heterogeneity of dysexecutive Alzheimer’s disease
Nick Corriveau‐Lecavalier, Leland R Barnard, Jeyeon Lee, et al.
Cerebral Cortex (2023) Vol. 33, Iss. 11, pp. 7026-7043
Open Access | Times Cited: 17
An ensemble learning model for continuous cognition assessment based on resting-state EEG
Jingnan Sun, Yike Sun, Anruo Shen, et al.
npj Aging (2024) Vol. 10, Iss. 1
Open Access | Times Cited: 8
Clinicopathologic Heterogeneity and Glial Activation Patterns in Alzheimer Disease
Naomi Kouri, Isabelle Frankenhauser, Zhongwei Peng, et al.
JAMA Neurology (2024) Vol. 81, Iss. 6, pp. 619-619
Open Access | Times Cited: 7
Page 1 - Next Page

Scroll to top